Orthocare Innovations Selected as a Top Grant Recipient by NIH
O&P Business NewsSeptember 14, 2008
Orthocare Innovations was selected by the National Institutes of Health (NIH) as a top phase II research award recipient for its work in the area of prosthetic alignment. In July, Orthocare presented at NIH's annual Small Business Innovation Research (SBIR)/Small Business Technology Transfer Programs Conference.
For the past decade, NIH has recognized awardees for outstanding commitment in transforming medicine through innovation. At the NIH conference, David Boone, CP, MHP, PhD, Orthocare Innovations' chief technology officer, presented the company's Computerized Prosthesis Alignment System (Compas™).
Alignment is an essential element in achieving optimal prosthetic function, and in maximizing patient comfort and use of prosthetic devices. Compas™ is a dynamic assessment and monitoring system that offers the promise of a sensitive gait laboratory in an onboard, lower limb prosthetic component to achieve and maintain optimal alignment.
This research and product development initiative was supported through phase I and phase II SBIR awards from the NIH's National Center for Medical Rehabilitation Research. Compas™ is not commercially available; Orthocare Innovations anticipates its launch in the third quarter of 2008, with initial introduction into the U.S. federal market.
Copyright © 2007 - 2012 Orthocare Innovations, LLC. All rights reserved.